THE LAWSUIT: A class action securities lawsuit was filed against Viatris Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 8, ...

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Follow us ...

Viatris will spend as much as $335 million to settle opioid-related claims against the Canonsburg-based pharmaceutical company. The proposed settlement over nine years would come in the form of ...

April 7 (Reuters) - Viatris (VTRS.O), opens new tab said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve claims by U.S. state and local ...

Viatris (NASDAQ:VTRS) extended gains for the seventh straight session on Monday as it rose 1.48% to close at $8.25. The drugmaker has added over 7% in the past six sessions, with its stock closing ...

Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday ...

With a market cap of $14.8 billion, Viatris Inc. (VTRS) is a global pharmaceutical company formed in 2020 through the merger of Mylan and Upjohn, a former Pfizer division. Headquartered in ...